Abstract:Measurement of aldosterone, renin, and aldosterone-renin ratio (ARR), are used to diagnose primary aldosteronism (PA). Immunoassays used to measure plasma aldosterone yield higher results compared to tandem mass spectrometry (LC-MS/MS). This can lead to false positive diagnosis of PA, and potential for unnecessary adrenal vein sampling. We report our development and validation of a novel test using LC-MS/MS, with reduced run time, for measurement of plasma aldosterone concentration (PAC) and plasma renin activity (PRA). The detection and quantification of plasma aldosterone and angiotensin 1 (product for the calculation of renin activity) in the mass spectrometer was based on the multiple reaction monitoring of precursor to fragment ions under negative and positive ionization modes, respectively. Validation of the tests were based on the CLSI (Clinical & Laboratory Standards Institute) guidelines. Concurrent measurement for 190 samples were done on our instrument, and on a commercial lab using LC-MS/MS (Mayo Laboratories, USA) for comparison. Our measurements of PAC and PRA was sensitive with a limit of quantification at 3 ng/dL and 0.25 ng/ml/h, respectively, and analytical run times were 6.5 min and 3.5 min, respectively. Both aldosterone and angiotensin 1 calibration curves had excellent linearity in the ranges of 3 - 300 ng/dL and 0.25 - 25 ng/ml/h, respectively, with coefficient of correlation, r2 > 0.994. The intra and inter day accuracy of aldosterone and angiotensin 1 were in the range of 95–110% with CV of < 13%. Reference ranges were established for our local population. Compared with the other LC-MS/MS laboratory, there was good correlation for PAC, r2 = 0.90, 95%CI: 0.86 - 0.92, and PRA, r2 = 0.81, 95% CI: 0.75 - 0.86, using 190 samples. In addition, amongst those with low aldosterone < 6ng/dL, there was good agreement between both labs, with 95 of 122 (77.9%) samples having low aldosterone using both methods, which has been shown to be an ideal threshold to exclude the diagnosis of PA. Our laboratory has developed and validated a sensitive and accurate LC-MS/MS test for PAC and PRA with shortened run time, for the diagnosis PA.

A 120-Minute Saline Infusion Test For The Confirmation Of Primary Aldosteronism: A Pilot Study

Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study

Comparison of saline infusion test and captopril challenge test in the diagnosis of Chinese with primary aldosteronism in different age groups

Clinical significance of LC-MS/MS aldosterone in screening for primary aldosteronism

Expanding the use of salivary cortisol as a non-invasive outpatient test in the dynamic evaluation of suspected adrenal insufficiency

PS-BPB04-9: DEVELOPMENT AND VALIDATION OF NEW METHOD TO MEASURE PLASMA ALDOSTERONE AND RENIN ACTIVITY USING LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETER (LC-MS/MS)

Comparison of four confirmatory tests for the diagnosis of primary aldosteronism: Bayesian analysis in the absence of a gold standard

Saline Suppression Testing-Induced Hypocalcemia and Implications for Clinical Interpretations

The role of confirmatory tests in the diagnosis of primary aldosteronism

Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done

Utility of Adrenal Vein Sampling With and Without Ultra-Low Dose ACTH Infusion in the Diagnostic Evaluation of Primary Aldosteronism

Comparison of three different chemiluminescence assays and a rapid liquid chromatography tandem mass spectrometry method for measuring serum aldosterone

Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2- h sampling

A single-centre experience of the implementation of adrenal vein sampling procedure: the impact on the diagnostic work-up in primary aldosteronism

Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling

Mass spectrometry-based cortisol profiling during adrenal venous sampling reveals misdiagnosis for subtyping primary aldosteronism

Preoperative supine time for adrenal venous sampling: a prospective randomized controlled trial

Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan

The Captopril Challenge Test for Diagnosing Primary Aldosteronism in a Chinese Population.

Comparison of a chemiluminescence immunoassay with LC-MS/MS in the determination of the plasma aldosterone concentration in patients with impaired renal function

Pre-test Cortisol Levels in Predicting Short Synacthen Test Outcome: A Retrospective Analysis